HueDx

Accelerating quantitative testing in Medical, R&D, Agro, & Industrial sectors
Overview
Raised: $0
Rolling Commitments ($USD)
08/12/2023
$0
2017
Healthcare & Pharmaceuticals
HealthTech
B2C
Medium
High
Summary Profit and Loss Statement
FY 2022 | FY 2021 | |
---|---|---|
Revenue |
$0 |
$0 |
COGS |
$0 |
$0 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$-1,617,497 |
$-1,270,604 |
Summary Balance Sheet
FY 2022 | FY 2021 | |
---|---|---|
Cash |
$37,320 |
$20,988 |
Accounts Receivable |
$0 |
$0 |
Total Assets |
$149,970 |
$229,334 |
Short-Term Debt |
$337,610 |
$341,499 |
Long-Term Debt |
$180,005 |
$296,874 |
Total Liabilities |
$517,615 |
$638,373 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual